v1.1 incorporates Dr. Dasari's own analysis of the old account. Every difference is shown in red below — struck-through means removed, highlighted means changed or added.
REMOVED — client correction: the program treats IBD, not IBS. IBS terms booked cheaply in history but those bookings don't fit the program.
Intestinal Inflammation — Symptom Languageadded
—
20%
$60
NEW — Dr. Dasari's insight, confirmed by the data: "treatment for intestinal inflammation" $272/conv, "inflamed large intestine treatment" $353/conv in the dedicated 2025 campaign. Non-specific symptom language beat diagnostic terms.
Treatment Seekers
20%
15%
$60$45
trimmed — inflammation cluster now carries its own budget
Brand Capture
5%
5%
$15
unchanged
Test Reserve
10%
15%
$30$45
widened — honors the 2025 "breadth wins" evidence via weekly term promotion
2 · Match-type doctrine — sentence added
Added to §2: "Match mix per the 2025 evidence: phrase-first with exact anchors on the proven winners (2025's winning breadth came from phrase coverage across themed campaigns); broad match enters only via the Test Reserve once the account has conversion mass." — per Dr. Dasari's observation that 2025's best performance came with the broadest phrase coverage.
3 · Exclusions — one row added
Added to §3: "IBS targeting — client correction (Aug 12): the program treats IBD, not IBS. Historical IBS terms booked cheaply (101 conversions on one 2024 keyword) but those bookings don't fit the program… All IBS terms excluded from the launch list." The 11 excluded terms are listed transparently at the bottom of the workbook's LAUNCH LIST sheet.
4 · Evidence attached
Added: the 2025-vs-2026 search-terms workbook (Dr. Dasari's XLS request) — per-campaign term detail, the 43-term launch list with campaign/match assignments, and 23 proven purchased keywords. Linked from §2 and the changelog.
5 · Related correction on the audit page
Audit §5 note corrected: "inflamed large intestine treatment" was previously framed only by its $745/conv post-consolidation figure. The note now shows both eras: $353/conv in the dedicated Intestinal Inflammation campaign before the March 2026 consolidation — the container degraded, not the keyword. This was the one place Dr. Dasari's analysis corrected ours.
Not changed: budget tiers and ramp, bidding doctrine (Max Clicks → Max Conversions, no tCPA), US-only geo, negatives program, ad-copy compliance rules, measurement gates, projections. v1.0 remains viewable at its immutable archive link above.